Use of an aggressive, estrogen receptor -negative MCF-7 cell line variant, TMX2 -28, to study breast cancer: Expression of PLD1, MIG2, SKP2, and PALM in human breast carcinomas

by Gozgit, Joseph M
Published 2007

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers

by Turk Casey M, Fagan-Solis Katerina D, Williams Kristin E, Gozgit Joseph M, Smith-Schneider Sallie, Marconi Sharon A, Otis Christopher N, Crisi Giovanna M, Anderton Douglas L, Kilimann Manfred W, Arcaro Kathleen F
Published 2012-05-01